Literature DB >> 8386774

Nm23 protein expression in ductal in situ and invasive human breast carcinoma.

J A Royds1, T J Stephenson, R C Rees, A J Shorthouse, P B Silcocks.   

Abstract

BACKGROUND: Mortality associated with human breast carcinoma is almost entirely due to subsequent metastatic disease, but the molecular basis of this metastasis is not understood. Elucidation of the genetic control of metastatic propensity of a tumor is important in determining prognosis and choice of therapy. Expression of nm23, a putative metastasis suppressor gene, has been detected in human breast cancers, but studies have not consistently shown high levels of the Nm23 messenger RNA or protein to be associated with better histological differentiation. This inconsistency suggests that Nm23 protein may act independently as a metastasis suppressor.
PURPOSE: The purpose of this retrospective study was to investigate the relationship of Nm23 protein expression with 1) histology in ductal breast carcinoma in situ and 2) the variables considered to be the major prognostic indicators in invasive breast carcinoma.
METHODS: We obtained formalin-fixed biopsy specimens of breast tissue excised from 128 patients with breast lesions detected by mammography. Of these patients, 35 had been diagnosed with benign breast disease, 26 with ductal carcinoma in situ (DCIS), and 67 with invasive carcinoma. Tissue sections were embedded in paraffin blocks, and immunohistochemical staining was used to determine Nm23 expression. Specimens were rated positive if all lesional epithelium was stained and negative if any lesional epithelium was unstained. Statistical analysis was performed by multiple regression analysis because of nonorthogonality of the data.
RESULTS: All 35 examples of benign breast disease showed uniform epithelial cell staining. The seven cases of comedo DCIS were negative for Nm23 protein; all 18 noncomedo types were positive. Nm23 negativity was significantly associated with worsening invasive ductal carcinoma grade and advancing lymph node stage but not with tumor diameter or vascular invasion. Despite the putative antimetastatic role of the nm23 gene, no statistically significant association was found between Nm23 protein expression and vascular invasion.
CONCLUSIONS: The precise role of the nm23 gene remains to be established, but our simplified immunohistochemical rating system shows an association between Nm23 protein expression and the two most significant prognostic factors relating to histologic grade and stage. Nm23 negativity distinguished comedo ductal carcinoma in situ from the other histological types, a finding consistent with the fact that comedo histology is known to have a higher likelihood of becoming invasive and of having higher cell proliferation rates and higher expression of growth factor (c-erb B2) receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386774     DOI: 10.1093/jnci/85.9.727

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  36 in total

Review 1.  AN OVERVIEW OF PROGNOSTIC MARKERS IN BREAST CANCER.

Authors:  G U Deshpande; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer.

Authors:  Ryusuke Terada; Toru Yasutake; Shirou Nakamura; Takashi Hisamatsu; Terumitsu Sawai; Hiroyuki Yamaguchi; Tohru Nakagoe; Hiroyoshi Ayabe; Yutaka Tagawa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

3.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

4.  High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas.

Authors:  George A Garinis; Evangelos N Manolis; Nick E Spanakis; George P Patrinos; George Peros; Panayiotis G Menounos
Journal:  J Mol Med (Berl)       Date:  2003-04-02       Impact factor: 4.599

5.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

6.  Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression.

Authors:  S R Grey; S S Dlay; B E Leone; F Cajone; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  NM23 protein in neoplastic and nonneoplastic thyroid tissues.

Authors:  P Bertheau; A De La Rosa; P S Steeg; M J Merino
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.

Authors:  Y Oda; H Walter; K Radig; I Röse; W Neumann; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.

Authors:  A R Howlett; O W Petersen; P S Steeg; M J Bissell
Journal:  J Natl Cancer Inst       Date:  1994-12-21       Impact factor: 13.506

Review 10.  Metastasis suppressor genes.

Authors:  Jinchun Yan; Qin Yang; Qihong Huang
Journal:  Histol Histopathol       Date:  2013-03       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.